Proliferation is probably an early event, followed by a chronic process that provides an essential fibrous cap that prevents plaque rupture. Several vascular diseases involve VSMC proliferation as ...

Background/aims Proton beam radiotherapy and plaque brachytherapy are commonly applied in primary uveal melanoma (UM); however, their effect on chromosome 3 classification of UM by microsatellite ...

The use of episcleral brachytherapy (EB) implant to treat intraocular tumours was introduced by Moore in 1930.3 The episcleral plaque design for retinoblastoma was popularised by Stallard.4 But it was ...

Active magnetic resonance (MR) tracking for gynecologic brachytherapy was made possible by attaching the microradiofrequency coils to the brachytherapy applicator. The rectangular planar microcoil was ...

(The Hill) — Two police officers who fended off rioters at the Capitol on Jan. 6, 2021, filed a lawsuit Thursday seeking to compel the installation of a plaque honoring law enforcement who defended ...

Two police officers who fended off rioters at the Capitol on Jan. 6, 2021, filed a lawsuit Thursday seeking to compel the installation of a plaque honoring law enforcement who defended the building… ...

The most common means of treating a cancerous tumor is using radiation therapy that involves a combination of both external and internal radiation treatments. To aid the clinician to plan for the ...

Accurate quantification of amyloid beta (Aβ) plaques is an important indicator for Alzheimer’s disease diagnosis and treatment. For this purpose, new highly sensitive Aβ tracers were designed by ...

The IAEA has developed a brachytherapy dosimetry methodology which serves as the basis for a new audit service provided by the Agency's Dosimetry Laboratory. For millions of cancer patients around the ...

The IAEA has developed a brachytherapy dosimetry methodology which serves as the basis for a new audit service provided by the Agency’s Dosimetry Laboratory. For millions of cancer patients around the ...

Compared with patients receiving placebo, those receiving colchicine showed a higher calcified plaque burden (adjusted difference, 2.4%), higher calcified plaque volume (adjusted difference, 59 mm ...